Conversio Health (Integrated Health Concepts Inc.), San Luis Obispo, CA
Is Conversio Health (Integrated Health Concepts Inc.) registered with the FDA as a 503B outsourcing facility?
No matching record found in FDA’s registered outsourcing facility list (updated Nov 6, 2026) on Nov 15, 2026, searching by name and location. FDA’s compounding inspections and actions page labels it a 503A facility.
Does Conversio Health (Integrated Health Concepts Inc.) hold a California pharmacy license?
The California State Board of Pharmacy lists 2 licenses for this name and city, as of Nov 6, 2026: LSC 99934 for Conversio Health, San Luis Obispo, status Active and PHY 51610 for Conversio Health, San Luis Obispo, status Active. The Texas State Board of Pharmacy also lists nonresident license 25699 for CONVERSIO HEALTH, SAN LUIS OBISPO, CA, status Active, as of Nov 15, 2026. The Colorado State Board of Pharmacy also lists nonresident license OSP 6091 for Conversio Health, San Luis Obispo, CA, status Active, as of Nov 15, 2026. The Illinois Department of Financial and Professional Regulation also lists nonresident license 054017809 for INTEGRATED HEALTH CONCEPTS INC, SAN LUIS OBISPO, CA, status CHANGE OF OWNERSHIP and license 054018370 for INTEGRATED HEALTH CONCEPTS INC, SAN LUIS OBISPO, CA, status REVOKED, as of Nov 13, 2026. The Connecticut Department of Consumer Protection also lists nonresident license PCN.0000832 for CONVERSIO HEALTH, San Luis Obispo, CA, status ACTIVE (CURRENT), as of Nov 15, 2026. The Delaware Division of Professional Regulation also lists nonresident license A9-0001453 for Integrated Health Concepts, Inc., SAN LUIS OBISPO, CA, status Expired, as of Nov 10, 2026.
Has Conversio Health (Integrated Health Concepts Inc.) had a state board action or FDA letter?
FDA letters: record found. FDA’s compounding inspections and actions page, current as of Oct 22, 2026, lists 1 warning letter (Sep 10, 2020), 1 warning letter close-out (Jan 18, 2022), 1 state referral letter (Jan 18, 2022) and 1 FMD-145 letter (Jan 18, 2022) for Conversio Health (Integrated Health Concepts Inc.). State board actions: record found. The California State Board of Pharmacy’s posted disciplinary decisions on facility licenses lists 2 actions: “Through a disciplinary action of the Board, the license is revoked, the revocation stayed, and the license is placed on probation for three years subject to the terms and conditions in the decision” dated Sep 1, 2021, case AC 6932 on license PHY 51610 and “Through a disciplinary action of the Board, the license is revoked, the revocation stayed, and the license is placed on probation for three years subject to the terms and conditions in the decision” dated Sep 1, 2021, case AC 6932 on license LSC 99934. The Colorado State Board of Pharmacy’s license dataset also lists 2 actions: “CLS Letter of Admonition” dated Jul 6, 2023, case 2023-2889 on nonresident license OSP 6091 and “CLS Letter of Admonition” dated Feb 22, 2021, case 2020-6624 on nonresident license OSP 6091. The Illinois Department of Financial and Professional Regulation’s license dataset also lists “Revocation” dated Jan 20, 2026, case 2023009033 on nonresident license 054018370. The state referral and handoff letters above are FDA’s letters to the state, not board actions.
FDA registers 503B outsourcing facilities; state boards of pharmacy license pharmacies, including 503A compounding pharmacies, and keep their own disciplinary records. Neither FDA list says which drugs a pharmacy makes.
- Names in FDA records
- Integrated Health Concepts Inc.; Conversio Health
- Location
- San Luis Obispo, CA
- Type as FDA labels it
- 503A
- FDA 503B list
- No matching record found
- Form 483s on FDA’s actions page
- 2
- Warning letters on FDA’s actions page
- 1
- Latest action on that page
- Jan 18, 2022
- FDA Data Dashboard inspections
- 2 inspections: 1 OAI, 1 VAI; 1 published Form 483
- Form 483 text on this page
- 1 Form 483, 2 observations
- State board records
- License found: LSC 99934, Active; PHY 51610, Active
FDA inspections and letters
FDA’s compounding inspections and actions page (current as of Oct 22, 2026) lists this pharmacy as Integrated Health Concepts Inc. (dba Conversio Health), a 503A facility, with 6 dated actions.
| Document | |||
|---|---|---|---|
| Jan 18, 2022 | State referral letter | State Referral Letter Issued 01/18/2022 | Not linked by FDA |
| Jan 18, 2022 | FMD-145 letter | FMD-145 Letter Issued 01/18/2022 | Not linked by FDA |
| Jan 18, 2022 | Warning letter close-out | Warning Letter Close Out Issued 01/18/2022 | Not linked by FDA |
| Jul 23, 2021 | Form 483 | 483 Issued 07/23/2021 | fda.gov |
| Sep 10, 2020 | Warning letter | Warning Letter (09/10/2020) | FDA copy (archived) |
| Sep 25, 2019 | Form 483 | 483 Issued 09/25/2019 | Not linked by FDA |
A Form 483 lists investigator observations, not a final FDA determination. A warning letter states FDA’s view when it was issued, not a court finding; any close-out letter FDA lists is a row of its own. An untitled or FMD-145 letter states FDA’s view when it was issued.
FDA inspection classifications and published Form 483s
The FDA Data Dashboard, read Nov 15, 2026, lists Integrated Health Concepts Inc., San Luis Obispo, CA (FEI number 3015131327), matched to this page by exact name, city and state. It lists 2 inspections: 1 OAI, 1 VAI at that site, newest first, with FDA’s classification as worded on the dashboard. Dashboard firm profile.
| Inspection ended | Classification | Project area and product type | FEI | Inspection ID |
|---|---|---|---|---|
| Jul 23, 2021 | Voluntary Action Indicated (VAI) | Drug Quality Assurance (Drugs) | 3015131327 | 1147046 |
| Sep 25, 2019 | Official Action Indicated (OAI) | Drug Quality Assurance (Drugs) | 3015131327 | 1106830 |
Form 483s FDA has published for this site
- Jul 23, 2021: Form 483 to Integrated Health Concepts Inc., published Oct 20, 2021. fda.gov
FDA classifies each inspection when it is closed: No Action Indicated (NAI) means no objectionable conditions were found or they did not justify further action; Voluntary Action Indicated (VAI) means objectionable conditions were found but FDA is not prepared to take or recommend regulatory action; Official Action Indicated (OAI) means FDA recommended regulatory or administrative action. A classification is FDA’s, not a finding by this site. The dashboard lists inspections once FDA has classified them, from fiscal year 2009 on, so a recent inspection may not appear yet.
Form 483 observations
A Form 483 lists an FDA investigator’s observations at the end of an inspection. It is not a final FDA determination. In FDA’s words: “The FDA Form 483 does not constitute a final Agency determination of whether any condition is in violation of the FD&C Act or any of its relevant regulations.” (FDA Form 483 FAQ). The firm may have answered or corrected these points; a response is not shown here unless FDA lists one.
FDA’s published Form 483 for this site has 2 numbered observations in all. Each observation is quoted from the PDF as FDA numbered it. Names of people on the form are not shown. What a Form 483 is; all 483s in this index.
Inspection Jul 12, 2021 to Jul 23, 2021: 2 observations
- Firm on the cover
- Integrated Health Concepts Inc., 720 Aerovista Pl Ste D, San Luis Obispo, CA 93401-8726
- FEI number
- 3015131327
- Establishment type on the cover
- Producer of Sterile Drugs
- FDA district office on the cover
- 1201 Harbor Bay Parkway Alameda, CA 94502-7070
- Matched to this page by
- FEI number on the cover; linked from actions page, Data Dashboard
- FDA document
- Read the full 483 (PDF on fda.gov)
Observation 1
Personnel touched equipment or other surfaces located outside of the ISO 5 classified aseptic processing area with gloved hands and then engaged in aseptic processing without changing or sanitizing gloves.
Specifically, on 07/14/21 we observed the operator fail to sanitize their gloves after touching equipment located on the ISO 7 mixing room table and before returning their gloves to handle materials within the ISO 5 Biological Safety Cabinet ( BSC) during <Redacted B4> of compounded inhalation drug product, Albuterol/lpratropium Bromide 2.5 mg/ 0.75 mg Solution for Nebulizer, Lot 071421-1, BUD 01/10/ 2022.
Observation 2
Personnel in an area that blocked the movement of first pass air around an open unit, either before or after it was filled with sterile product.
Specifically, on 7/14/21 we observed the operator place an IV bag containing <Redacted B4> drug product over the ISO 5 BSC air return vents, blocking downward airflow for approximately ten (10) seconds following <Redacted B4> of compounded inhalation drug product, Albuterol/lpratropium Bromide 2.5 mg/ 0 .75 mg Solution for Nebulizer, Lot 071421-1, BUD 01/ 10/ 2022 .
State board of pharmacy records
The California State Board of Pharmacy file dated Nov 6, 2026 lists these licenses under the same name, city and state as this pharmacy. Board file.
| License | Type as the board gives it | Name on the board record | City | Status |
|---|---|---|---|---|
| LSC 99934 | Resident Licensed Sterile Compounding | Conversio Health | San Luis Obispo | Active |
| PHY 51610 | Retail Pharmacy | Conversio Health | San Luis Obispo | Active |
Board actions
As the board words them, newest first. An entry that is a complaint, charge or notice the board filed is a charge, not a final decision; only an order or final action records the outcome.
- Sep 1, 2021: “Through a disciplinary action of the Board, the license is revoked, the revocation stayed, and the license is placed on probation for three years subject to the terms and conditions in the decision.”, license PHY 51610, case AC 6932, Conversio Health, San Luis Obispo, CA. Board list
- Sep 1, 2021: “Through a disciplinary action of the Board, the license is revoked, the revocation stayed, and the license is placed on probation for three years subject to the terms and conditions in the decision.”, license LSC 99934, case AC 6932, Conversio Health, San Luis Obispo, CA. Board list
What this covers: Facility license decisions from the board’s quarterly Disciplinary Actions pages (87 of 88 quarters had a facility section). These are final decisions; accusations filed and immediate protection orders are not included. Actions in the data are dated Jan 5, 2005 to Oct 28, 2026.
Nonresident licenses in other states
These boards list a nonresident license whose record names this pharmacy’s own name, city and state.
Texas State Board of Pharmacy, file dated Nov 15, 2026 (Texas).
| License | Type as the board gives it | Name on the board record | Location | Status | Prior disciplinary orders (file flag) |
|---|---|---|---|---|---|
| 25699 | Non Resident Sterile Compounding | CONVERSIO HEALTH | SAN LUIS OBISPO, CA | Active | Yes |
Colorado State Board of Pharmacy, file dated Nov 15, 2026 (Colorado).
| License | Type as the board gives it | Name on the board record | Location | Status |
|---|---|---|---|---|
| OSP 6091 | OSP | Conversio Health | San Luis Obispo, CA | Active |
- Jul 6, 2023: “CLS Letter of Admonition”, license OSP 6091, case 2023-2889, Conversio Health, San Luis Obispo, CA. Board document
- Feb 22, 2021: “CLS Letter of Admonition”, license OSP 6091, case 2020-6624, Conversio Health, San Luis Obispo, CA. Board document
Illinois Department of Financial and Professional Regulation, file dated Nov 13, 2026 (Illinois).
| License | Type as the board gives it | Name on the board record | Location | Status |
|---|---|---|---|---|
| 054017809 | LICENSED PHARMACY | INTEGRATED HEALTH CONCEPTS INC | SAN LUIS OBISPO, CA | CHANGE OF OWNERSHIP |
| 054018370 | LICENSED PHARMACY | INTEGRATED HEALTH CONCEPTS INC | SAN LUIS OBISPO, CA | REVOKED |
- Jan 20, 2026: “Revocation”, license 054018370, case 2023009033, INTEGRATED HEALTH CONCEPTS INC, SAN LUIS OBISPO, CA. Reason given in the record: “pharmacy license has been revoke after adverse actions were taken against Respondent by California, Maine, Kansas, and Colorado, and Respondent failed to report them to the Department.” Board list
Connecticut Department of Consumer Protection, file dated Nov 15, 2026 (Connecticut).
| License | Type as the board gives it | Name on the board record | Location | Status |
|---|---|---|---|---|
| PCN.0000832 | NONRESIDENT PHARMACY | CONVERSIO HEALTH | San Luis Obispo, CA | ACTIVE (CURRENT) |
Delaware Division of Professional Regulation, file dated Nov 10, 2026 (Delaware).
| License | Type as the board gives it | Name on the board record | Location | Status |
|---|---|---|---|---|
| A9-0001453 | Non Resident Pharmacy | Integrated Health Concepts, Inc. | SAN LUIS OBISPO, CA | Expired |
This page restates FDA’s lists and state board of pharmacy records. A Form 483, letter or board action is not a finding by this site, and a missing record is not a finding either way. A state license is matched only on the same name, city and state. Follow each link for the original document. Report an error or add a company response.
Sources
- FDA: Compounding: Inspections, Recalls, and other Actions
- FDA Registered Outsourcing Facilities (503B)
- FDA Data Dashboard: inspection classifications and published Form 483s
- FDA: FDA Form 483 Frequently Asked Questions
- California State Board of Pharmacy license file
- Texas State Board of Pharmacy license file
- Colorado State Board of Pharmacy license file
- Illinois Department of Financial and Professional Regulation license file
- Connecticut Department of Consumer Protection license file
- Delaware Division of Professional Regulation license file
- California State Board of Pharmacy disciplinary records
- Texas State Board of Pharmacy disciplinary records
- Delaware Division of Professional Regulation disciplinary records
Records last pulled Nov 15, 2026. Every entry links to the original public record.